Phase 3 prospective, randomized, controlled, open-label, multicenter, crossover study of recombinant ADAMTS13 in patients with congenital thrombotic thrombocytopenic purpura - Scully, M; Windyga, J; Mellgard, B; Ortel, T L; Li, H; Ayash-Rashkovsky, M; Cataland, S WL (2023)
. ISTH Abstract.